Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3Infertility 1Anovulation 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Clomiphene × 90 days × Clear all
NCT07616973 2026-06-01

LET-CC-TAM

Sana'a University

Phase 3 Active not recruiting
240 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT06813118 2026-05-07

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

HITEC-Institute of Medical Sciences

Phase 1 Completed
42 enrolled

Polycystic Ovary Syndrome

NCT03059173 2026-04-22

MYOPK

University Hospital, Lille

Phase 3 Recruiting
276 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡